findmyKOL
Clinical trialNCT06906497RecruitingPhase 4Interventional

Lebrikizumab in Moderate-to-severe Atopic Dermatitis

SponsorJohann E Gudjonsson MD PhDEnrollment48Atopic Dermatitis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This research is studying a drug already approved for the treatment of atopic dermatitis (AD). This research collects health-related information and blood and skin samples to understand if the study drug, lebrikizumab, leads to long-term improvement in AD skin.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • University of Freiburg

    Freiburg im Breisgau, Germany

    Kilian Eyerich
    Not, yet, recruiting
Switzerland
  • Lausanne University Hospital

    Lausanne, Switzerland

    Conrad Curdin, MD
    Not, yet, recruiting
United States
  • Physioseq Usa - Ca

    Folsom, California, United States

    Emanual Maverakis, MD
    Recruiting
  • University of Michigan

    Ann Arbor, Michigan, United States

    Johann E. Gudjonsson, MD, PhD
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Lebrikizumab →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Jul 2025
Primary completion
31 Jul 2027
Completion
31 Jul 2027
Last update posted
11 Aug 2025
Registered enrollment
48
Registry id
NCT06906497
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.